Patents Assigned to Immunetech, Inc.
-
Patent number: 8349620Abstract: A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in aqueous suspension. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.Type: GrantFiled: December 6, 2011Date of Patent: January 8, 2013Assignee: ImmuneTech, Inc.Inventors: Christopher R. Brown, James T. Murai
-
Patent number: 8093066Abstract: A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in aqueous suspension. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.Type: GrantFiled: January 13, 2011Date of Patent: January 10, 2012Assignee: ImmuneTech, Inc.Inventors: Christopher R. Brown, James T. Murai
-
Patent number: 8034631Abstract: A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in aqueous suspension. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.Type: GrantFiled: January 13, 2011Date of Patent: October 11, 2011Assignee: ImmuneTech, Inc.Inventors: Christopher R. Brown, James T. Murai
-
Patent number: 8034632Abstract: A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in aqueous suspension. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.Type: GrantFiled: January 13, 2011Date of Patent: October 11, 2011Assignee: ImmuneTech, Inc.Inventors: Christopher R. Brown, James T. Murai
-
Patent number: 7892853Abstract: A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in aqueous suspension. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.Type: GrantFiled: December 16, 2008Date of Patent: February 22, 2011Assignee: ImmuneTech, Inc.Inventors: Christopher R. Brown, James T. Murai
-
Patent number: 7491553Abstract: A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in aqueous suspension. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.Type: GrantFiled: April 10, 2007Date of Patent: February 17, 2009Assignee: ImmuneTech, Inc.Inventors: Christopher R. Brown, James T. Murai
-
Publication number: 20070190668Abstract: A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in aqueous suspension. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.Type: ApplicationFiled: April 10, 2007Publication date: August 16, 2007Applicant: Immunetech, Inc.Inventors: Christopher Brown, James Murai
-
Publication number: 20030232397Abstract: A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in aqueous suspension. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.Type: ApplicationFiled: March 12, 2003Publication date: December 18, 2003Applicant: Immunetech, Inc.Inventors: Christopher R. Brown, James T. Murai
-
Publication number: 20030109067Abstract: A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in suspension with 1-5 &mgr;L of undiluted sample. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.Type: ApplicationFiled: December 6, 2001Publication date: June 12, 2003Applicant: ImmuneTech, Inc.Inventors: Christopher R. Brown, James T. Murai
-
Patent number: 4686282Abstract: Polypeptides which are immunotherapeutic agents which block immune complex binding to immunoglobulin Fc receptors are produced.Type: GrantFiled: August 12, 1983Date of Patent: August 11, 1987Assignee: Immunetech, Inc.Inventor: Gary S. Hahn
-
Patent number: 4683292Abstract: An active site peptide which blocks immune complex binding to Fc receptors, the peptide having an amino acid sequence selected from the group consisting of:A-B-C-D-E-F-G-H-I-J-K-L-M-N-O-P,or a subgroup thereof,whereinA is Arg, Lys, Orn, Gln, or His;B is Ser, Thr, Ala, or Gly;C is Thr, Ser, Ala, or Gly;D is Thr, Ser, Ala, or Gly;E is Lys, Arg, Orn or His;F is Thr, Ser, Ala, or Gly;G is Ser, Thr, Ala, or Gly;H is Gly, Ala, Thr, Ser, Lys, Arg, or OrnI is Pro, Val, Leu, Ile, or Ala;J is Arg, Lys, Orn, or His;K is Ala, Thr, Ser, or Gly;L is Ala, Thr, Ser, or Gly;M is Pro, Val, Leu, Ile, or Ala;N is Glu, or Asp;O is Val, Leu, Ile, or Ala;P is Tyr, or Phe.and pharmaceutically acceptable salts thereof.Type: GrantFiled: August 12, 1983Date of Patent: July 28, 1987Assignee: Immunetech, Inc.Inventor: Gary S. Hahn